Global Gene Recombinant Protein Market Growth (Status and Outlook) 2024-2030

Global Gene Recombinant Protein Market Growth (Status and Outlook) 2024-2030

Genetically recombinant protein is a protein produced using genetic engineering technology.

The global Gene Recombinant Protein market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Gene Recombinant Protein Industry Forecast” looks at past sales and reviews total world Gene Recombinant Protein sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Recombinant Protein sales for 2023 through 2029. With Gene Recombinant Protein sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Recombinant Protein industry.

This Insight Report provides a comprehensive analysis of the global Gene Recombinant Protein landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Recombinant Protein portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Recombinant Protein market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Recombinant Protein and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Recombinant Protein.

United States market for Gene Recombinant Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Gene Recombinant Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Gene Recombinant Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Gene Recombinant Protein players cover Thermo Fisher Scientific, Eurogentec, GenScript, OriGene, Sino Biological, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Recombinant Protein market by product type, application, key players and key regions and countries.

Segmentation by Type:
Cytokines
Plasma Protein Factors
Recombinant Hormone
Interferon
Growth Factors
Clotting Factor
Enzyme
Others

Segmentation by Application:
Pharmaceutical
Scientific Research
Cosmetic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Cytokines
Plasma Protein Factors
Recombinant Hormone
Interferon
Growth Factors
Clotting Factor
Enzyme
Others

Segmentation by Application:
Pharmaceutical
Scientific Research
Cosmetic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Eurogentec
GenScript
OriGene
Sino Biological
Abgenex
Promega
Bio - Techne
Merck KGaA
Abcam PLC
Cytiva
Abnova Corporation
Ajinomoto
Miltenyi Biotec
Bio-Techne Corporation
ACROBiosystems
Reprocell
BPS Bioscience
ProSpec Tany TechnoGene

Please note: The report will take approximately 2 business days to prepare and deliver.